Barriers to food allergy management among Americans with low income

Alexandria Bozen; Justin M. Zaslavsky; Dara Cohn; Waheeda Samady; Lisa Lombard; Kari Nadeau; Mary Tobin; Christopher M. Warren; Ruchi S. Gupta

doi:10.1016/j.anai.2020.05.007

Barriers to food allergy management among Americans with low income

Alexandria Bozen, Justin M. Zaslavsky, Dara Cohn, Waheeda Samady, Lisa Lombard, Kari Nadeau, Mary Tobin, Christopher M. Warren, Ruchi S. Gupta

Research output: Contribution to journal › Article › peer-review

8 Scopus citations

Original language	English (US)
Pages (from-to)	341-343
Number of pages	3
Journal	Annals of Allergy, Asthma and Immunology
Volume	125
Issue number	3
DOIs	https://doi.org/10.1016/j.anai.2020.05.007
State	Published - Sep 2020

ASJC Scopus subject areas

Pulmonary and Respiratory Medicine
Immunology and Allergy
Immunology

Access to Document

10.1016/j.anai.2020.05.007

Cite this

@article{3b8677b0d57048a6903d5464bff723b3,

title = "Barriers to food allergy management among Americans with low income",

author = "Alexandria Bozen and Zaslavsky, {Justin M.} and Dara Cohn and Waheeda Samady and Lisa Lombard and Kari Nadeau and Mary Tobin and Warren, {Christopher M.} and Gupta, {Ruchi S.}",

note = "Funding Information: Disclosures: Dr Gupta reports receiving grants from the National Institutes of Health (R21 ID no. AI135705, R01 ID no. AI130348, and U01 ID no. AI138907), Rho Inc., Sean N. Parker Center for Allergy Research, UnitedHealth Group, Thermo Fisher Scientific, Genentech, and the National Confectioners Association; and serves as a medical consultant and advisor for Before Brands Inc., Kal?o Inc., Genentech, Institute for Clinical and Economic Review, Food Allergy Research and Education (FARE), Aimmune Therapeutics, and DBV Technologies. Dr Nadeau received grant support from the NIAID, Food Allergy Research & Education, End Allergies Together, AllerGenis, and Ukko; personal fees from Regeneron, AstraZeneca, ImmuneWorks, and Cour; research sponsorship from Novartis, Sanofi, Astellas, and Nestle; and research sponsorship for clinical trials from Genentech, Aimmune Therapeutics, DBV Technologies, AnaptysBio, Stallergenes-Greer, Regeneron, and Adare Pharmaceuticals and is a Data and Safety Monitoring Board member at Novartis and the National Heart, Lung, and Blood Institute (NHLBI); cofounded Before Brands, Alladapt Immunotherapeutics, and ForTra; is a grant awardee for the NIAID, NHLBI, National Institute of Environmental Health Sciences (NIEHS), and US Environmental Protection Agency (EPA); and is Director for Food Allergy Research & Education and the World Allergy Organization Center of Excellence. The remaining authors have no conflicts of interest to report.Funding: This study was funded by The Sean N. Parker Center for Allergy and Asthma Research at Stanford University. Funding Information: Funding: This study was funded by The Sean N. Parker Center for Allergy and Asthma Research at Stanford University . ",

year = "2020",

month = sep,

doi = "10.1016/j.anai.2020.05.007",

language = "English (US)",

volume = "125",

pages = "341--343",

journal = "Annals of Allergy, Asthma and Immunology",

issn = "1081-1206",

publisher = "American College of Allergy, Asthma and Immunology",

number = "3",

}

TY - JOUR

T1 - Barriers to food allergy management among Americans with low income

AU - Bozen, Alexandria

AU - Zaslavsky, Justin M.

AU - Cohn, Dara

AU - Samady, Waheeda

AU - Lombard, Lisa

AU - Nadeau, Kari

AU - Tobin, Mary

AU - Warren, Christopher M.

AU - Gupta, Ruchi S.

N1 - Funding Information: Disclosures: Dr Gupta reports receiving grants from the National Institutes of Health (R21 ID no. AI135705, R01 ID no. AI130348, and U01 ID no. AI138907), Rho Inc., Sean N. Parker Center for Allergy Research, UnitedHealth Group, Thermo Fisher Scientific, Genentech, and the National Confectioners Association; and serves as a medical consultant and advisor for Before Brands Inc., Kal?o Inc., Genentech, Institute for Clinical and Economic Review, Food Allergy Research and Education (FARE), Aimmune Therapeutics, and DBV Technologies. Dr Nadeau received grant support from the NIAID, Food Allergy Research & Education, End Allergies Together, AllerGenis, and Ukko; personal fees from Regeneron, AstraZeneca, ImmuneWorks, and Cour; research sponsorship from Novartis, Sanofi, Astellas, and Nestle; and research sponsorship for clinical trials from Genentech, Aimmune Therapeutics, DBV Technologies, AnaptysBio, Stallergenes-Greer, Regeneron, and Adare Pharmaceuticals and is a Data and Safety Monitoring Board member at Novartis and the National Heart, Lung, and Blood Institute (NHLBI); cofounded Before Brands, Alladapt Immunotherapeutics, and ForTra; is a grant awardee for the NIAID, NHLBI, National Institute of Environmental Health Sciences (NIEHS), and US Environmental Protection Agency (EPA); and is Director for Food Allergy Research & Education and the World Allergy Organization Center of Excellence. The remaining authors have no conflicts of interest to report.Funding: This study was funded by The Sean N. Parker Center for Allergy and Asthma Research at Stanford University. Funding Information: Funding: This study was funded by The Sean N. Parker Center for Allergy and Asthma Research at Stanford University .

PY - 2020/9

Y1 - 2020/9

UR - http://www.scopus.com/inward/record.url?scp=85086699595&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85086699595&partnerID=8YFLogxK

U2 - 10.1016/j.anai.2020.05.007

DO - 10.1016/j.anai.2020.05.007

M3 - Article

C2 - 32437837

AN - SCOPUS:85086699595

SN - 1081-1206

VL - 125

SP - 341

EP - 343

JO - Annals of Allergy, Asthma and Immunology

JF - Annals of Allergy, Asthma and Immunology

IS - 3

ER -

Barriers to food allergy management among Americans with low income

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this